Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May-Jun;33(3):237-249.
doi: 10.20524/aog.2020.0474. Epub 2020 Mar 27.

Pulmonary manifestations of chronic liver disease: a comprehensive review

Affiliations
Review

Pulmonary manifestations of chronic liver disease: a comprehensive review

Stergios Soulaidopoulos et al. Ann Gastroenterol. 2020 May-Jun.

Abstract

Hepatopulmonary syndrome (HPS) and porto-pulmonary hypertension (PoPH) represent relatively common pulmonary vascular complications of advanced liver disease. Despite distinct differences in their pathogenetic background, both clinical states are characterized by impaired arterial oxygenation and limited functional status, and are associated with increased pre-transplantation mortality. Accumulation of ascitic fluid in the pleural cavity, known as hepatic hydrothorax (HH), is another frequent manifestation of decompensated cirrhosis, which may cause severe respiratory dysfunction, depending on the volume of the effusion, the rapidity of its development and its resistance to therapeutic measures. Orthotopic liver transplantation constitutes the only effective treatment able to resolve the pulmonary complications of liver disease. A prioritization policy for liver transplantation has evolved over the past years regarding advanced stages of HPS, yielding favorable outcomes regarding post-transplantation survival and HPS resolution. In contrast, severe PoPH is associated with poor post-transplantation survival. Hence, liver transplantation is recommended only for patients with PoPH and an acceptable reduction in pulmonary pressure values, after receiving PoPH-targeted vasodilating therapy. This review focuses on basic pathogenetic and diagnostic principles and discusses the current therapeutic approaches regarding HPS, PoPH, and HH.

Keywords: Cirrhosis; chronic liver disease; hepatopulmonary syndrome; liver transplantation; porto-pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Diagnostic algorithm for patients with chronic liver disease and dyspnea RVSP, right ventricular systolic pressure; mPAP, mean pulmonary arterial pressure; PVR, pulmonary vascular resistance; PAWP, pulmonary artery wedge pressure; IPVS, intrapulmonary vascular shunting; ECHO, echocardiography; P(A-a)O2, Alveolar-arterial oxygen pressure gradient; POPH, portopulmonary hypertension; HPS, hepatopulmonary syndrome

References

    1. Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver-induced lung vascular disorder. N Engl J Med. 2008;358:2378–2387. - PubMed
    1. Hervé P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998;11:1153–1166. - PubMed
    1. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD) Eur Respir J. 2004;24:861–880. - PubMed
    1. Chang SC, Chang HI, Chen FJ, Shiao GM, Wang SS, Lee SD. Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites. J Hepatol. 1997;26:833–838. - PubMed
    1. Soulaidopoulos S, Cholongitas E, Giannakoulas G, Vlachou M, Goulis I. Review article:Update on current and emergent data on hepatopulmonary syndrome. World J Gastroenterol. 2018;24:1285–1298. - PMC - PubMed

LinkOut - more resources